| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |